Pyramid Biosciences

Pyramid Biosciences is dedicated to discovering and developing targeted therapies for a variety of diseases regulated by the tropomyosin receptor kinase (TRK) family. By precisely and selectively modulating the activity of these essential cell surface receptors, they can control key signaling pathways responsible for patients' diseases, conditions, or symptoms.